Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.

Scientific reports - 10 Jun 2022

Sheikhpour Mojgan, Delorme Vincent, Kasaeian Alibakhsh, Amiri Vahid, Masoumi Morteza, Sadeghinia Mohammad, Ebrahimzadeh Nayereh, Maleki Mobina, Pourazar Shahin

Abstract excerpt

Drug resistance in tuberculosis is exacerbating the threat this disease is posing to human beings. Antibiotics that were once effective against the causative agent, Mycobacterium tuberculosis (Mtb), are now no longer usable against multi- and extensively drug-resistant strains of this pathogen. To address this issue, new drug combinations and novel methods for targeted drug delivery could be of considerable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluoxetine

Share to Isoniazid

Share to Mycobacterium tuberculosis

Share to Nanoparticles

Share to Tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed Open full text

Identifiers

PMID: 35688860
DOI: 10.1038/s41598-022-13682-4
PMCID: PMC9185718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An effective nano drug delivery and combination therapy for the treatment of Tuberculosis.PMID 35688860Read ↗

An effective Nano Drug Delivery and combination therapy for the treatment of TuberculosisSemantic proximity Read ↗

Bactericidal activity of ZnO nanoparticles-anti TB drugs combination towards H37Rv strain and multidrug-resistant isolates of <i>Mycobacterium tuberculosis</i> via SufB splicing inhibitionSemantic proximity Read ↗

Innovative Strategies for Combating Multidrug-Resistant Tuberculosis: Advances in Drug Delivery Systems and TreatmentSemantic proximity Read ↗

Preparation, Characterization, and in-vitro Cytotoxicity of Nanoliposomes Loaded With Anti-tuberculous Drugs and TGF-β1 Sirna for Improving Spinal Tuberculosis TherapySemantic proximity Read ↗

Preparation, characterrization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tuberculous drugs and TGF-β1 siRNA for improving spinal tuberculosis therapySemantic proximity Read ↗

A new methodology for simultaneous comparison and optimization between nanoparticles and their drug conjugates against various multidrug-resistant bacterial strainsSemantic proximity Read ↗

A novel C-4-modified isotetrone acts as a potent bio-enhancer to augment the activities of anti-tuberculosis drugs against Mycobacterium tuberculosis.Semantic proximity Read ↗

The synergic effect of garlic extract and astragalus extract-green synthesized CuO nanoparticles on tuberculosis infection: An in vivo studySemantic proximity Read ↗

In Vitro and In Vivo Efficacy of NITD-916 against Mycobacterium fortuitumSemantic proximity Read ↗

Nano-antibiotics combined with laser irradiation to reduce the development of drug resistance of K. Pneumoniae and accelerate wound healingSemantic proximity Read ↗

Nano delivery of MiR-146a and its Effect Study on Genes Involved in Apoptosis and Autophagy Pathways in Lung Cancer and TuberculosisSemantic proximity Read ↗

Deferoxamine as adjunct therapeutics for tuberculosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.